- Home
- ACGLO vs SCLXW Comparison
ACGLO vs SCLXW Comparison
Compare ACGLO & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACGLO
- SCLXW
- Stock Information
- Founded
- ACGLO N/A
- SCLXW N/A
- Country
- ACGLO Bermuda
- SCLXW United States
- Employees
- ACGLO 5800
- SCLXW 111
- Industry
- ACGLO Property-Casualty Insurers
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- ACGLO Finance
- SCLXW Health Care
- Exchange
- ACGLO Nasdaq
- SCLXW Nasdaq
- Market Cap
- ACGLO N/A
- SCLXW N/A
- IPO Year
- ACGLO N/A
- SCLXW N/A
- Fundamental
- Price
- ACGLO $20.56
- SCLXW $0.10
- Analyst Decision
- ACGLO
- SCLXW
- Analyst Count
- ACGLO 0
- SCLXW 0
- Target Price
- ACGLO N/A
- SCLXW N/A
- AVG Volume (30 Days)
- ACGLO N/A
- SCLXW 4.0K
- Earning Date
- ACGLO N/A
- SCLXW 03-07-2025
- Dividend Yield
- ACGLO N/A
- SCLXW N/A
- EPS Growth
- ACGLO N/A
- SCLXW N/A
- EPS
- ACGLO N/A
- SCLXW N/A
- Revenue
- ACGLO N/A
- SCLXW $55,152,000.00
- Revenue This Year
- ACGLO N/A
- SCLXW N/A
- Revenue Next Year
- ACGLO N/A
- SCLXW N/A
- P/E Ratio
- ACGLO N/A
- SCLXW N/A
- Revenue Growth
- ACGLO N/A
- SCLXW 22.02
- 52 Week Low
- ACGLO N/A
- SCLXW $0.18
- 52 Week High
- ACGLO N/A
- SCLXW $0.18
- Technical
- Relative Strength Index (RSI)
- ACGLO 52.32
- SCLXW N/A
- Support Level
- ACGLO $20.52
- SCLXW N/A
- Resistance Level
- ACGLO $20.77
- SCLXW N/A
- Average True Range (ATR)
- ACGLO 0.19
- SCLXW 0.00
- MACD
- ACGLO 0.02
- SCLXW 0.00
- Stochastic Oscillator
- ACGLO 67.12
- SCLXW 0.00
About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.